XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.24.3

STOCK-BASED COMPENSATION | 9 Months Ended
--- | ---
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract] |
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION The Equity Plan governs the Company’s restricted stock grants and stock options. Total compensation cost charged against income related to the Equity Plan was $109 and $167 for the three months ended September 30, 2024 and September 30, 2023, respectively, and $281 and $486 for the nine months ended September 30, 2024 and September 30, 2023, respectively. Restricted Stock The Company awarded shares of restricted common stock to certain employees and non-employee directors for which compensation expense is recognized ratably over the vesting period of the awards based on the fair value of the stock at issue date. A summary of changes in the Company’s nonvested restricted shares for the nine months ended September 30, 2024 and September 30, 2023 follows:
| Shares |  | Weighted-Average Grant-Date Fair Value, per share
Nonvested at January 1, 2024 | 52,195 |  |  | $ | 18.75 |
Granted | 30,650 |  |  | 11.70 |
Vested | (29,835) |  |  | (18.24) |
Forfeited | (1,125) |  |  | (16.05) |
Nonvested at September 30, 2024 | 51,885 |  |  | $ | 14.93 |
| Shares |  | Weighted-Average Grant-Date Fair Value, per share
Nonvested at January 1, 2023 | 22,000 |  |  | $ | 21.52 |
Granted | 46,175 |  |  | 18.30 |
Vested | (13,935) |  |  | (20.01) |
Forfeited | (1,865) |  |  | (19.38) |
Nonvested at September 30, 2023 | 52,375 |  |  | $ | 18.75 |
At September 30, 2024, there was $456 of total unrecognized compensation cost related to nonvested restricted shares granted under the Equity Plan that is expected to be recognized over a weighted average period of 3.0 years. The total fair value of shares vested during the nine months ended September 30, 2024 and September 30, 2023 was $359 and $252, respectively. Stock Options The Equity Plan permits the grant of stock options to the Company’s employees and non-employee directors for up to 15% of the total number of shares of Company common stock issued and outstanding, up to 1,500,000 shares. Option awards are granted with an exercise price equal to the market price of the Company’s common stock at the date of grant. The market price of the Company’s common stock is the closing sales price of the Common Stock on Nasdaq on the date of the grant. Those option awards generally have a vesting period of 5 years for employees and 3 years for non-employee directors and have 10-year contractual terms. The fair value of each option award is estimated on the date of grant using a closed form option valuation (Black-Scholes) model that uses the assumptions noted in the table below. Expected volatility is based on an average of historical volatility of peer financial institutions. The expected term of options granted represents the period of time that options granted are expected to be outstanding, which takes into account that the options are not transferable. The risk-free interest rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. A summary of the activity in the Equity Plan for the nine months ended September 30, 2024 and September 30, 2023 follows:
| Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value
Outstanding at January 1, 2024 | 367,033 |  |  | $ | 15.68 |  |  |  |  |
Forfeited | (2,970) |  |  | (15.56) |  |  |  |  |
Outstanding at September 30, 2024 | 364,063 |  |  | $ | 15.57 |  |  | 4.92 |  | $ | — |
Vested and exercisable at September 30, 2024 | 349,385 |  |  | $ | 15.71 |  |  | 4.88 |  | $ | — |
| Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value
Outstanding at January 1, 2023 | 405,688 |  |  | $ | 15.67 |  |  |  |  |
Exercised | (30,375) |  |  | (15.71) |  |  |  |  |
Forfeited | (7,980) |  |  | (15.51) |  |  |  |  |
Outstanding at September 30, 2023 | 367,333 |  |  | $ | 15.67 |  |  | 5.93 |  | $ | — |
Vested and exercisable at September 30, 2023 | 323,022 |  |  | $ | 15.79 |  |  | 5.78 |  | $ | — |
There were no options granted during the three and nine months ended September 30, 2024 or September 30, 2023. Total unrecognized compensation cost related to nonvested stock options granted under the Equity Plan was $23 at September 30, 2024. This cost is expected to be recognized over a weighted average period of 1.2 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration